Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy
- PMID: 9693181
- DOI: 10.1159/000017971
Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy
Abstract
Background and objective: Local PUVA (psoralen plus UVA light) is an effective outpatient treatment for patients with palmoplantar eczema or psoriasis. In this study, the efficacy, applicability and patient acceptance of two local forms of 8-methoxypsoralen (8-MOP) PUVA therapy were compared.
Methods: The study design was a left-right comparison (n = 37): the left hand or foot was treated with (aqueous) 8-MOP bath PUVA whereas the right received (ethanolic) 8-MOP lotion PUVA. After 1 month, the more successful treatment was continued on both sides until lesions cleared.
Results: Both therapies were effective and both useful for particular clinical applications: patients with erosive lesions and rhagades appreciated the gentleness of bath PUVA. Those with pustules or hyperkeratotic lesions appreciated the greater effectiveness of 8-MOP lotion PUVA. The total UVA dose and number of sessions to clearance were smaller with 8-MOP lotion. There was no difference in the length of the relapse-free period. Therapy nonresponders usually became apparent within the first 12 sessions.
Conclusions: The difference between bath PUVA and lotion PUVA can be described as 'gentle' versus 'strong' therapy. The better therapy depends on clinical indication.
Similar articles
-
Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.Photodermatol Photoimmunol Photomed. 2006 Feb;22(1):1-5. doi: 10.1111/j.1600-0781.2006.00196.x. Photodermatol Photoimmunol Photomed. 2006. PMID: 16436174 Clinical Trial.
-
PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study.Photodermatol Photoimmunol Photomed. 2005 Apr;21(2):62-7. doi: 10.1111/j.1600-0781.2005.00134.x. Photodermatol Photoimmunol Photomed. 2005. PMID: 15752122 Clinical Trial.
-
Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.Int J Dermatol. 2005 Apr;44(4):337-9. doi: 10.1111/j.1365-4632.2004.02153.x. Int J Dermatol. 2005. PMID: 15811091
-
[Consensus document on bath-PUVA therapy. The Spanish Photobiology Group of the Spanish Academy of Dermatology and Venereology].Actas Dermosifiliogr. 2007 Apr;98(3):164-70. doi: 10.1016/s0001-7310(07)70040-6. Actas Dermosifiliogr. 2007. PMID: 17504700 Spanish.
-
Modulation of cytokine production by 8-methoxypsoralen and UVA.J Dermatol Sci. 1999 Feb;19(2):114-22. doi: 10.1016/s0923-1811(98)00067-x. J Dermatol Sci. 1999. PMID: 10098702 Review.
Cited by
-
Phototherapy for atopic eczema.Cochrane Database Syst Rev. 2021 Oct 28;10(10):CD013870. doi: 10.1002/14651858.CD013870.pub2. Cochrane Database Syst Rev. 2021. PMID: 34709669 Free PMC article.
-
Interventions for chronic palmoplantar pustulosis.Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD001433. doi: 10.1002/14651858.CD001433.pub2. Cochrane Database Syst Rev. 2006. PMID: 16437433 Free PMC article.
-
Psoralen plus ultraviolet A (PUVA) soaks and UVB TL01 treatment for chronic hand dermatoses.Dermatol Reports. 2012 Feb 7;4(1):e3. doi: 10.4081/dr.2012.e3. eCollection 2012 Jan 2. Dermatol Reports. 2012. PMID: 25386313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical